@article{611bf53dafd54b41b5a73f29bafe297f,
title = "When All Else Fails: The Use of Electroconvulsive Therapy for Conditions Other than Major Depressive Episode",
abstract = "The use of electroconvulsive therapy (ECT) for those suffering from major depressive disorder is well-evidenced, time-honored, and recognized by most treatment guidelines. However, since its inception ECT has been used by practitioners for a broader range of neuropsychiatric conditions. This article reviews the highly variable evidence supporting the use of ECT in conditions other than depression, such as schizophrenia, bipolar manic states, catatonia, Parkinson disease, and post-traumatic stress disorder.",
keywords = "Bipolar disorder, Catatonia, Electroconvulsive therapy, Indications, Mania, Post-traumatic stress disorder, Schizophrenia",
author = "Rosenquist, {Peter B.} and Youssef, {Nagy Adel} and Sandarsh Surya and McCall, {William V.}",
note = "Funding Information: Dr P.B. Rosenquist discloses current research funding from NIMH (R01MH09S776A1), American Foundation for Suicide Prevention, Lumosity Corporation (66324S-13), Merck (8S0073-9), ALS Association, GlaxoSmithKline, Harvard Stem Cell Institute, Neurologic Clinical Research Institute (701419-18), and MECTA Corporation (72200S-2). Dr N.A. Youssef discloses current research supported by American Foundation for Suicide Prevention (DIG-0-087-13), Merck, MECTA Corporation, ABR Corporation, and Veterans Administration. Dr S. Surya has no disclosures. Dr W.V. McCall discloses current research support from NIMH, American Foundation for Suicide Prevention, Merck, and MECTA Corporation. Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",
year = "2018",
month = sep,
doi = "10.1016/j.psc.2018.04.002",
language = "English (US)",
volume = "41",
pages = "355--371",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "3",
}